Singapore markets close in 35 minutes

The Fight Against COVID19

The Fight Against COVID19

15.53k followers13 symbols Watchlist by TREA

Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.

Curated by TREA

TREA analyzes over 100 million data points, interactions, relationships on company research and development activities, allowing investors to quickly gain insight without having to go through complex regulatory filings. Primary data sources include: FDA (Food and Drug Administration), NIH (National Institutes of Health), USPTO (US Patent and Trademark Office). The search parameters for generating this watchlist were (1) Above sector average Innovation Index score, (2) IP history at least 5 years (3) COVID19 (4) 2019-nCov (5) SARS-CoV-2 among others.


WatchlistChange today1-month return1-year returnTotal return
The Fight Against COVID19-4.44%---

13 symbols

SymbolCompany nameLast priceChange% changeMarket timeVolumeAvg vol (3-month)Market cap
JNJJohnson & Johnson144.44+0.23+0.16%4:00 pm GMT-48.66M6.19M380.28B
PFEPfizer Inc.36-0.25-0.69%4:02 pm GMT-421.67M27.69M200.05B
ABBVAbbVie Inc.87.14-1.46-1.65%4:02 pm GMT-46.21M7.01M153.79B
SNYSanofi50.61+0.75+1.50%4:00 pm GMT-41.43M983.15k128.06B
GSKGlaxoSmithKline plc37.79-0.21-0.55%4:00 pm GMT-43.33M2.86M94.63B
GILDGilead Sciences, Inc.63.09-0.31-0.49%4:00 pm GMT-48.52M8.71M79.10B
REGNRegeneron Pharmaceuticals, Inc.565.19-6.32-1.11%4:00 pm GMT-4535.66k756.26k60.13B
TAKTakeda Pharmaceutical Company Limited18.6+0.01+0.05%4:00 pm GMT-41.18M998.90k60.09B
MRNAModerna, Inc.67.16-1.56-2.27%4:00 pm GMT-46.92M19.72M26.50B
BNTXBioNTech SE63.83-3.22-4.80%4:00 pm GMT-41.68M3.61M15.20B
NVAXNovavax, Inc.101.57-10.06-9.01%4:00 pm GMT-43.15M7.71M6.22B
VIRVir Biotechnology, Inc.33.43+0.54+1.64%4:00 pm GMT-4671.16k1.38M4.25B
INOInovio Pharmaceuticals, Inc.15.97-1.01-5.95%4:00 pm GMT-421.02M32.80M2.68B
  • Coronavirus update: Johnson & Johnson vaccine enters phase 3 as Fauci heads to Senate
    Editor's pick
    Yahoo Finance

    Coronavirus update: Johnson & Johnson vaccine enters phase 3 as Fauci heads to Senate

    Johnson & Johnson announced that its coronavirus vaccine candidate had entered the pivotal human trial phase that will enroll up to 60,000 participants worldwide.

  • Gilead Sciences Prices $7.25 Billion of Senior Unsecured Notes
    Business Wire

    Gilead Sciences Prices $7.25 Billion of Senior Unsecured Notes

    Gilead Sciences, Inc. (Nasdaq: GILD) today announced the pricing of senior unsecured notes in an aggregate principal amount of $7.25 billion, in an underwritten, registered public offering, consisting of seven tranches:

  • Gilead to pay $97 million to settle U.S. kickback probe

    Gilead to pay $97 million to settle U.S. kickback probe

    Gilead Sciences Inc has agreed to pay $97 million to resolve U.S. government claims it used a purportedly independent charity to pay illegal kickbacks to cover Medicare patients' out-of-pocket costs for its pulmonary arterial hypertension drug Letairis. The U.S. Department of Justice said on Wednesday the settlement resolves allegations that Gilead improperly used the Caring Voice Coalition as a conduit to cover thousands of patients' co-payment obligations. "Gilead used data from CVC that it knew it should not have, and effectively set up a proprietary fund within CVC to cover the co-pays of just its own drug," U.S. Attorney Andrew Lelling in Boston said in a statement.